Orca-T vs allogeneic hematopoietic stem cell transplantation (Precision-T): a multicenter, randomized phase 3 trial

Overview of attention for article published in Blood, December 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 8 news outlets
blogs: 1 blog
twitter: 21 X users
wikipedia: 1 Wikipedia page

reddit: 1 Redditor
guideline: 1 clinical guideline source
bluesky: 2 Bluesky users

Readers on

mendeley: 28 Mendeley

So far, Altmetric has seen 24 X posts from 21 X users, with an upper bound of 30,938 followers.

Orca-T vs allogeneic hematopoietic stem cell transplantation (Precision-T): a multicenter, randomized phase 3 trial | Blood | American Society of Hematology https://t.co/kr0RXxMGju

Orca-T, an allogeneic T-cell immunotherapy uses purified donor regulatory T cells to prevent GVHD. In a randomized phase 3 study, Orca-T significantly improved survival free from cGVHD compared to conventional alloHSCT with Tac/MTX. https://t.co/ClKKre…

RT @BLLPHD: Orca-T Phase 3 trial data https://t.co/nzAN8CSuPQ https://t.co/OlIiOuxv0d

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 20 additional X posts.